Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 435, Issue 1, 2013, Pages 46-51

  Gao, Yao Hui ^a   Li, Cai Xia ^a   Shen, Shao Ming ^a   Li, Hui ^a   Chen, Guo Qiang ^a   Wei, Qing ^b   Wang, Li Shun ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

HIF 1 ; PVHL; ROS; SOD2

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; SHORT HAIRPIN RNA; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MOLECULAR MECHANICS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STABILITY;

BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL HYPOXIA; CELL LINE, TUMOR; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPEROXIDE DISMUTASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84878167968     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.034     Document Type: Article

References (19)

1. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
2. 2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
3. Fukuda R., Kelly B., Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003, 63:2330-2334.
4. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
5. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
6. Tang C.M., Yu J. Hypoxia-inducible factor-1 as a therapeutic target in cancer. J. Gastroenterol. Hepatol. 2013, 28:401-405.
7. Liao S.H., Zhao X.Y., Han Y.H., Zhang J., Wang L.S., Xia L., Zhao K.W., Zheng Y., Guo M., Chen G.Q. Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells. Proteomics 2009, 9:3901-3912.
8. Zhao X.Y., Chen T.T., Xia L., Guo M., Xu Y., Yue F., Jiang Y., Chen G.Q., Zhao K.W. Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells. Carcinogenesis 2010, 31:1367-1375.
9. Rigoulet M., Yoboue E.D., Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid. Redox Signal. 2010, 14:459-468.
10. Guzy R.D., Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 2006, 91:807-819.
11. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., Budinger G.R., Chandel N.S. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
12. Sasabe E., Yang Z., Ohno S., Yamamoto T. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells. Free Radic. Biol. Med. 2010, 48:1321-1329.
13. Shen S.M., Yu Y., Wu Y.L., Cheng J.K., Wang L.S., Chen G.Q. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells. Carcinogenesis 2010, 31:419-426.
14. Pan X., Zhou T., Tai Y.H., Wang C., Zhao J., Cao Y., Chen Y., Zhang P.J., Yu M., Zhen C., Mu R., Bai Z.F., Li H.Y., Li A.L., Liang B., Jian Z., Zhang W.N., Man J.H., Gao Y.F., Gong W.L., Wei L.X., Zhang X.M. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Nat. Med. 2011, 17:708-714.
15. Song L.P., Zhang J., Wu S.F., Huang Y., Zhao Q., Cao J.P., Wu Y.L., Wang L.S., Chen G.Q. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Oncogene 2008, 27:519-527.
16. Soini Y., Vakkala M., Kahlos K., Paakko P., Kinnula V. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J. Pathol. 2001, 195:156-162.
17. Yang L.Y., Chen W.L., Lin J.W., Lee S.F., Lee C.C., Hung T.I., Wei Y.H., Shih C.M. Differential expression of antioxidant enzymes in various hepatocellular carcinoma cell lines. J. Cell Biochem. 2005, 96:622-631.
18. Narravula S., Colgan S.P. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 2001, 166:7543-7548.
19. Erler J.T., Cawthorne C.J., Williams K.J., Koritzinsky M., Wouters B.G., Wilson C., Miller C., Demonacos C., Stratford I.J., Dive C. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell Biol. 2004, 24:2875-2889.